Multicenter, Retrospective Korean Coronary Bifurcation Stenting (COBIS) Registry III
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,648
- 试验地点
- 1
- 主要终点
- Target lesion failure
研究概览
简要总结
The COBIS III registry is a multi-center, real-world registry of 2nd generation drug-eluting stenting in coronary bifurcation lesions in South Korea. From 21 major coronary intervention centers in Korea, a total of 3,000 patients (anticipated) will be enrolled in this database between January 2010 and December 2014.
The aim of the study was to investigate long-term clinical results and predictors of adverse outcomes after percutaneous coronary intervention with 2nd generation drug-eluting stents for coronary bifurcation lesions in South Korea.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 19 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age >=19 years
- •Any type of de novo bifurcation lesion in major epicardial artery: unprotected left main coronary bifurcation lesion, LAD - diagonal, LCX-OM, distal RCA bifurcation. (Excluding RCA-RV branch bifurcation, branch bifurcation)
- •Side branch or LCX reference diameter >= 2.3 mm and at least stentable with 2.5 mm stent
- •Treated with drug-eluting stent during the period of
排除标准
- •Protected left main disease previous CABG for LAD or LCX territory
- •Cardiogenic Shock
- •History of CPR in the same hospitalization
- •Patients with severe left ventricular systolic dysfunction (ejection fraction < 30%)
结局指标
主要结局
Target lesion failure
时间窗: 5 years
composite of cardiac death, myocardial infarction, or target lesion revascularization
次要结局
- Cardiac death(5 years)
- Myocardial infarction(5 years)
- Target lesion revascularization(3 years)
- Stent thrombosis(5 years)
研究者
Hyeon-Cheol Gwon
Professor
Samsung Medical Center
